June 25, 2013 (Shareholders Foundation) - An investigation on behalf of investors of Solazyme Inc (NASDAQ:SZYM) shares over potential securities laws violations by Solazyme and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Solazyme Inc (NASDAQ:SZYM) concerning whether a series of statements by Solazyme Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Solazyme Inc reported that its annual Total Revenue rose from $9.16 million in 2009 to $44.11 million in 2012 and that its Net Loss of $13.67 million in 2009 increased to $83.13 million in 2012.
Shares of Solazyme Inc (NASDAQ:SZYM) declined from $25.49 per share in July 2011 to as low as $6.88 per share in November 2012.

For the first quarter in 2013 Solazyme Inc. reported a first quarter Revenue in 2013 of $6.68 million compared to $13.56 million in 2012 and a 2013 first quarter Net Loss of $26.52 million, compared to $16.78 million in 2012

On June 24, 2013, Solazyme Inc disclosed that on June 21, 2013, Solazyme, Inc. and Roquette Frres, S.A. agreed to dissolve their joint venture, Solazyme Roquette Nutritionals, LLC, in accordance with Articles 20 and 21 of the Joint Venture and Operating Agreement of Solazyme Roquette Nutritionals, LLC.

Shares of Solazyme Inc (NASDAQ:SZYM) declined from $12.62 per share on June 21, 2013, to $10.11 per share on June 24, 2013.